title: Effectiveness of low-dose indinavir/ritonavir at 400/100 mg twice a day with 2 nucleoside reverse transcriptase inhibitors in nonnucleoside reverse transcriptase inhibitor-experienced HIV-infected patients in India: 1-year follow-up.
authors.forename: Atul K
authors.initials: AK
authors.lastname: Patel
authors.forename: Ketan K
authors.initials: KK
authors.lastname: Patel
authors.forename: Jagdish K
authors.initials: JK
authors.lastname: Patel
authors.forename: Rakesh L
authors.initials: RL
authors.lastname: Sharma
authors.forename: Rajiv R
authors.initials: RR
authors.lastname: Ranjan
mesh_terms: D000328:Adult; D000368:Aged; D018791:CD4 Lymphocyte Count; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007194:India; D019469:Indinavir / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*
chemical_list: D018894:Reverse Transcriptase Inhibitors; D019469:Indinavir; D019438:Ritonavir